Efficacy of Leflunomide Compared to Methotrexate in the Treatment of Moderate to Severe Plaques Psoriasis: A Randomized Controlled Clinical Trial
Introduction: Psoriasis is a chronic inflammatory autoimmune skin disease. Several treatment options are available including topical and systemic options. Methotrexate was the main systemic medication in treating severe psoriasis, yet adverse events can limit its use. Leflunomide is an isoxazole der...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Mattioli1885
2024-07-01
|
| Serija: | Dermatology Practical & Conceptual |
| Teme: | |
| Online pristup: | https://dpcj.org/index.php/dpc/article/view/4021 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|